Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major advancement in image-guided navigation for prostate cancer care with the FDA 510(k) clearance of the latest

皇家飞利浦(NYSE: PHG, AEX: PHIA)，全球健康技术领域的领导者，今天宣布在前列腺癌护理的图像引导导航方面取得了重大进展，最新产品获得了FDA 510(k)许可。

Philips UroNav version

飞利浦 UroNav 版本

. The system includes a new advanced annotation [1] workflow that supports clinicians during focal therapy procedures, helping deliver more precise, minimally invasive care.

该系统包括一个新的高级注释[1]工作流程，该工作流程在局灶治疗过程中为临床医生提供支持，有助于提供更精确、微创的护理。

This release comes at a time of increasing need for innovation in prostate cancer care. Prostate cancer remains the most commonly diagnosed solid tumor among men in the United States, with over 313,000 new cases, 1 in 8 men will be diagnosed with prostate cancer in their lifetime [2]. While many prostate cancers are slow-growing, overtreatment can lead to quality-of-life degradation, including incontinence and sexual dysfunction, prompting growing interest in focal therapies that offer a targeted, tissue-sparing alternative for appropriate patients..

此版本发布的时机正值前列腺癌护理领域对创新需求日益增长之际。前列腺癌仍然是美国男性中最常被诊断的实体肿瘤，每年有超过31.3万的新病例，每8名男性中就有1人会在其一生中被诊断出患有前列腺癌 [2]。尽管许多前列腺癌生长缓慢，但过度治疗可能导致生活质量下降，包括尿失禁和性功能障碍，这促使人们对局部疗法的兴趣日益增加，这种疗法为合适的患者提供了有针对性且保留组织的替代方案。

“We’re entering a new era of precision prostate cancer care. Philips’ integrated focal therapy platform unifies imaging, biopsy pathology, treatment planning and 3D imaging guidance with MR US fusion giving clinicians end to end efficiency and control,” said Dr. Ardeshir Rastinehad, Vice Chair of Urology at Lenox Hill Hospital and System Director of Prostate Cancer at Northwell Health.

“我们正在进入精准前列腺癌治疗的新时代。飞利浦的集成焦点治疗平台将影像、活检病理学、治疗规划和 MR US 融合的 3D 影像引导相结合，为临床医生提供端到端的效率和控制，”莱诺克斯山医院泌尿科副主席兼北岸医疗系统前列腺癌项目总监阿德尔希尔·拉斯坦哈德博士表示。

“With fused imaging and real time ablation guidance in one place, we can personalize therapy with greater accuracy and spare patients the unnecessary side effects of traditional treatments.”.

“通过在一个平台上融合成像和实时消融引导，我们可以更精确地个性化治疗，并避免患者遭受传统治疗带来的不必要的副作用。”

As an image fusion system, UroNav seamlessly integrates pre-procedural imaging, such as Magnetic Resonance Imaging (MRI), with real-time intra-procedural imaging from ultrasound (US) systems. This innovative combination enhances the precision and accuracy of therapeutic procedures, providing clinicians with a comprehensive and dynamic view of the targeted area..

作为图像融合系统，UroNav 无缝集成了术前成像（如磁共振成像 (MRI)）与来自超声波 (US) 系统的实时术中成像。这一创新组合提高了治疗程序的精确性和准确性，为临床医生提供了目标区域的全面而动态的视图。

A more targeted approach means a more informed treatment selection and patients receive better and more precise care and clinicians are supported in better diagnosis, a 30% improvement in high-risk prostate cancer diagnosis using fusion biopsy compared to the standard biopsy [3]. The new advanced annotation workflow works in tandem with .

更有针对性的方法意味着更明智的治疗选择，患者得到更好、更精确的护理，临床医生也得到更好的诊断支持，使用融合活检相较于标准活检，高风险前列腺癌诊断提升了30% [3]。新的高级注释工作流程与此协同工作。

DynaCAD Urology

DynaCAD 泌尿科

to support focal therapy planning, deliver and review, reducing complexity and enabling a broader group of clinicians to offer minimally invasive options.

支持焦点治疗规划、实施和审查，降低复杂性，使更多临床医生能够提供微创选项。

“We’re helping clinicians deliver more precise prostate cancer care by streamlining complex workflows and delivering the insights they need to support precise diagnosis and expand options for minimally invasive treatments,” said Martijn Hartjes, Business Leader, Clinical Informatics at Philips. “Our goal is to equip clinicians with the clinical tools required so they can deliver better care for more patients.” .

飞利浦临床信息学业务主管马蒂恩·哈特曼斯表示：“我们通过简化复杂的工作流程，提供支持精确诊断所需的见解，帮助临床医生提供更精准的前列腺癌治疗方案，并扩大微创治疗的选择范围。我们的目标是为临床医生配备所需的临床工具，以便他们能够为更多患者提供更好的护理。”

In addition to clinical functionality, Philips UroNav delivers enhanced compatibility with ultrasound devices and needle guides, upgraded privacy and security protections, and seamless integration with Philips DynaCAD systems for radiology and urology.

除了临床功能外，飞利浦 UroNav 还增强了与超声设备和针头导向器的兼容性，升级了隐私和安全保护，并与飞利浦 DynaCAD 系统无缝集成，用于放射学和泌尿科。

Philips’ comprehensive urology portfolio integrates imaging, biopsy, therapy guidance, and digital pathology to support precision diagnosis and treatment—enabling clinicians to tailor care with greater efficiency and confidence.

飞利浦全面的泌尿科产品组合整合了成像、活检、治疗引导和数字病理学，以支持精准诊断和治疗——使临床医生能够更高效、更自信地定制护理方案。